AXGN

AXGN

USD

Axogen Inc. Common Stock

$23.770+0.710 (3.079%)

Echtzeitkurs

Healthcare
Medizinprodukte
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$23.060

Hoch

$23.830

Tief

$22.920

Volumen

0.27M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.1B

Branche

Medizinprodukte

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.10M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $9.22Aktuell $23.770Hoch $23.83

Ähnliche Nachrichten

GlobeNewswire

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

ALACHUA, Fla. and TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

Mehr anzeigen
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $26

HC Wainwright & Co. analyst Yi Chen maintains Axogen with a Buy and raises the price target from $25 to $26.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $26
Analyst Upgrades

Raymond James Maintains Outperform on Axogen, Raises Price Target to $27

Raymond James analyst Jayson Bedford maintains Axogen with a Outperform and raises the price target from $20 to $27.

Mehr anzeigen
Raymond James Maintains Outperform on Axogen, Raises Price Target to $27
Analyst Upgrades

Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $27

Canaccord Genuity analyst Caitlin Cronin maintains Axogen with a Buy and raises the price target from $24 to $27.

Mehr anzeigen
Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $27
Analyst Upgrades

Citizens Maintains Market Outperform on Axogen, Raises Price Target to $34

Citizens analyst David Turkaly maintains Axogen with a Market Outperform and raises the price target from $26 to $34.

Mehr anzeigen
Citizens Maintains Market Outperform on Axogen, Raises Price Target to $34
GlobeNewswire

Axogen, Inc. Reports Third Quarter 2025 Financial Results

ALACHUA, Fla. and TAMPA, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

GlobeNewswire

Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025

ALACHUA, Fla. and TAMPA, Fla., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,